diabetes and more
53.7K views | +0 today
Follow
 
Scooped by Ellen H Ullman, MSW
onto diabetes and more
Scoop.it!

Congress Take Note: 29 Million Diabetic Americans Wonder 'Who is Minding the Diabetes Supply Store?' | Commentary

Congress Take Note: 29 Million Diabetic Americans Wonder 'Who is Minding the Diabetes Supply Store?' | Commentary | diabetes and more | Scoop.it
You see the small, handmade signs at the intersections of streets across the country, touting “CASH PAID FOR DIABETES TEST STRIPS.”  Signs of the times? Perhaps, as ad hoc resellers of medical supplies provide a secondary market to someone in need of a few quick dollars while possibly flouting pesky safety laws. But it’s also an indicator of a larger-scale issue: the difficulty faced by federal policymakers in regulating a multifaceted industry crucial to the…
more...
No comment yet.
diabetes and more
Important news for those concerned with all types of diabetes, associated autoimmune diseases, & health
Your new post is loading...
Your new post is loading...
Scooped by Ellen H Ullman, MSW
Scoop.it!

JDRF - New Research Advisory Committee formed to support people with type 1 diabetes

JDRF - New Research Advisory Committee formed to support people with type 1 diabetes | diabetes and more | Scoop.it
JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today the formation of a new external Research Advisory Committee (RAC) comprised of individuals internationally renowned for their expertise in research as well as the care and treatment of those with T1D.
Ellen H Ullman, MSW's insight:

"to bring the greatest good for the largest number of people in the shortest amount of time."  - The majority of the people worldwide with t1 diabetes will not benefit from the artificial pancreas - they need a biological cure.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Potential diabetes treatment advances

Potential diabetes treatment advances | diabetes and more | Scoop.it
Device shields beta cells from immune system attack | Researchers at MIT’s David H. Koch Institute for Integrative Cancer Research, in collaboration with scientists at the Harvard Stem Cell Institute and several other institutions, have developed an implantable device that in mice shielded insulin-producing beta cells from immune system attack for six months — a substantial proportion of life span.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Engineered micro-pancreas helps transplanted islet cells to live longer

Engineered micro-pancreas helps transplanted islet cells to live longer | diabetes and more | Scoop.it
A newly-developed micro-pancreas can prevent transplanted islet cells from failing, potentially overcoming one of the biggest problems with islet cell transplantation for people with type 1 diabetes. The platform, known as the engineered micro-pancreas (EMP), is developed by Israeli biotech company Betalin Therapeutics. It solves several of the difficulties associated with islet cell transplantation. Researchers know how to transplant islet cells to people with type 1 diabetes, and they know how to make those cells work. What they don't know is how to stop those cells from failing. Half of islet cell transplant patients are back on insulin injections with a year; 90 per cent within five years.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

FULL TEXT - A child with type 1 diabetes mellitus (T1DM) successfully treated with the Paleolithic ketogenic diet: A 19-month insulin freedom - International Journal of Case Reports and Images (IJCRI)

FULL TEXT - A child with type 1 diabetes mellitus (T1DM) successfully treated with the Paleolithic ketogenic diet: A 19-month insulin freedom - International Journal of Case Reports and Images (IJCRI) | diabetes and more | Scoop.it
Introduction: Currently type 1 diabetes mellitus (T1DM) is treated with insulin and a high carbohydrate diet. In the literature, however, there are studies indicating that low carbohydrate diets may be beneficial in reducing hypoglycemic episodes as well as the need for insulin. Previously we reported a case of a 19-year-old T1DM patient who was successfully treated with a modified version of the ketogenic diet we refer to as the Paleolithic ketogenic diet. Case Report: Here we provide a case study of a 9-year-old child with T1DM who initially was on an insulin regime with high carbohydrate diet then was put on the Paleolithic ketogenic diet. Following dietary shift glucose levels normalized and he was able to discontinue insulin. No hypoglycemic episodes occurred on the diet and several other benefits were achieved including improved physical fitness, reduction of upper respiratory tract infections and eczema. Currently he is on the diet for 19 months. Conclusion: Adopting the Paleolithic ketogenic diet ensured normoglycemia without the use of external insulin. The diet was sustainable on the long-term. Neither complications nor side-effects emerged on the diet.
Ellen H Ullman, MSW's insight:

SHARING WITH AN ABUNDANCE OF CAUTION.  THERE IS NOTHING HEALTHFUL ABOUT THIS DIET IN A 9 YEAR OLD GROWING CHILD IMO.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Two Big Wins For A UConn Medical Device Startup- Implantable Sensor - size of a grain of rice

Two Big Wins For A UConn Medical Device Startup- Implantable Sensor - size of a grain of rice | diabetes and more | Scoop.it
STORRS — It's been a whirlwind fall season at Biorasis, a startup biomedical company at UConn.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Artificial Pancreas Could Be Operated by a Smartphone

Artificial Pancreas Could Be Operated by a Smartphone | diabetes and more | Scoop.it
RT @SamISureAm: Managing #Diabetes could be much easier with a smartphone-operated #ArtificialPancreas
https://t.co/lhUqZNMI1Y https://t.c
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Researchers Coax Leftover Pancreatic Cells to Morph Into Insulin-Producing Cells - EndocrineWeb

Researchers Coax Leftover Pancreatic Cells to Morph Into Insulin-Producing Cells - EndocrineWeb | diabetes and more | Scoop.it
Using a growth factor produced naturally by the human body – and used in spinal-fusion surgeries – scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have coaxed “leftover” cells from the...
Ellen H Ullman, MSW's insight:

Rodent studies.  Next step "animal studies".  Let's hope HUMANS will someday benefit from this research.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

“You Can’t Eat That!” – the effect of words on diabetes, research by Jane K. Dickinson

Jane K. Dickinson is a nurse and Certified Diabetes Educator, who has been living with type 1 diabetes for 40 years. In 1993 Jane gave her first talk on the ...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Immunotherapy for type 1 diabetes deemed safe in first US trial

Immunotherapy for type 1 diabetes deemed safe in first US trial | diabetes and more | Scoop.it
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes (T1D), led by UC San Francisco scientists and physicians, patients experienced no serious adverse reactions after receiving infusions of as many as 2.6 billion cells that had been specially selected to protect the body's ability to produce insulin.
Ellen H Ullman, MSW's insight:

I'd like to see the data!  Your thoughts? 

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Oral Insulin Capsule to Replace Injections - NOT READY FOR PRIME TIME!

Oral Insulin Capsule to Replace Injections - NOT READY FOR PRIME TIME! | diabetes and more | Scoop.it
A way to deliver insulin in a capsule that can be taken orally has been developed with the hope that it can replace injections for people with diabetes.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Scientists create insulin-producing cells that may treat diabetes | EurekAlert! Science News

Scientists create insulin-producing cells that may treat diabetes | EurekAlert! Science News | diabetes and more | Scoop.it
A new technique to produce cells with insulin-secretion capabilities has been developed, according to research presented today at the 54th Annual European Society for Paediatric Endocrinology Meeting. The technique could be further developed to be used in the transplantation for patients with type 1 diabetes.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Insulin-Producing Pancreatic Cells Could Be The Next Big Thing In Cure Of Diabetics

Insulin-Producing Pancreatic Cells Could Be The Next Big Thing In Cure Of Diabetics | diabetes and more | Scoop.it
A team of scientists has discovered cells in the human body that could potentially be used to harness insulin to cure diabetics.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Home Use of an Artificial Beta Cell in Type 1 Diabetes — NEJM

Original Article from The New England Journal of Medicine — Home Use of an Artificial Beta Cell in Type 1 Diabetes
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Scott's Web Log: Just Who Is JDRF Therapeutic Ventures, LLC? Why is it such a secret?

Scott's Web Log: Just Who Is JDRF Therapeutic Ventures, LLC? Why is it such a secret? | diabetes and more | Scoop.it
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Beyond Fitness Trackers At CES: Tiny Wearable Biosensor Continuously Monitors Your Body Chemistry

Beyond Fitness Trackers At CES: Tiny Wearable Biosensor Continuously Monitors Your Body Chemistry | diabetes and more | Scoop.it
Forbes Welcome page -- Forbes is a global media company, focusing on business, investing, technology, entrepreneurship, leadership, and lifestyle.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

7 New Diabetes Products to Look for in 2016

7 New Diabetes Products to Look for in 2016 | diabetes and more | Scoop.it
Looking ahead to 2016, we’re optimistic about these seven diabetes products potentially hitting the market in the next 12 months.
more...
Scooped by Ellen H Ullman, MSW
Scoop.it!

Small cap Nemaura raises $10M, starts JV for EU launch of patch-based glucose monitor

Small cap Nemaura raises $10M, starts JV for EU launch of patch-based glucose monitor | diabetes and more | Scoop.it
Nemaura Medical stealthily listed on the Nasdaq OTC market late last year. That followed a corporate restructuring in late 2013. All this is in the name of developing a novel continuous glucose monitoring system that includes a disposable patch, a watch and a smartphone app--that the company has dubbed SugarBeat.
Ellen H Ullman, MSW's insight:

Hopefully it's better than the old Glucowatch!

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Tweet from @Diabetes_DRI

Tweet from @Diabetes_DRI | diabetes and more | Scoop.it
What do human islets have in common with animal islets? See answer here: instagram.com/p/-319ghFBpX/ #t1d #science pic.twitter.com/gaKzSQG6xu
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Current Research into Cures for Type-1 Diabetes via Joshua Levy

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Orgenesis and Biosequel Enter Collaboration Agreement for Conducting Clinical ... - CNNMoney

Orgenesis and Biosequel Enter Collaboration Agreement for Conducting Clinical ... - CNNMoney | diabetes and more | Scoop.it
Orgenesis and Biosequel Enter Collaboration Agreement for Conducting Clinical ...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

INGAP IS BACK? Landmark clinical trial of a novel combination treatment for type 1 diabetes

INGAP IS BACK?  Landmark clinical trial of a novel combination treatment for type 1 diabetes | diabetes and more | Scoop.it
Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people with longstanding type 1 diabetes. The treatment combines INGAP Peptide (ExsulinTM), which stimulates growth of the insulin secreting islets, and ustekinumab (SteleraTM), a drug approved for the treatment of psoriasis.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

The Doctor on a Quest to Save Our Medical Devices From Hackers

The Doctor on a Quest to Save Our Medical Devices From Hackers | diabetes and more | Scoop.it
Dr. David Klonoff is spearheading an effort to eliminate dangerous security holes in insulin pumps, which could help secure other medical devices as well.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Richard Vaughn Interviewed by Daniele Hargenrader - Unleash Your Inner Diabetes Dominator, Episode 25 - The Diabetes Dominator™

Richard Vaughn Interviewed by Daniele Hargenrader - Unleash Your Inner Diabetes Dominator, Episode 25 - The Diabetes Dominator™ | diabetes and more | Scoop.it
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

4-drug mixture reverses Type 1 diabetes in mice

4-drug mixture reverses Type 1 diabetes in mice | diabetes and more | Scoop.it
Call it the scientist’s version of happy hour: A new, four-drug cocktail has shown a novel ability to reverse established Type 1 diabetes in some mice, University of Florida Health researchers have found.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

EASD Virtual Meeting - Prof. Steven Russel The Bionic Pancreas: When will the dream come true?

EASD Virtual Meeting - Prof. Steven Russel The Bionic Pancreas: When will the dream come true? | diabetes and more | Scoop.it
Randomized cross-over design (11 days bionic pancreas, 11 days usual care)Subjects work or study on one of four campusesMGH, UNC Chapel Hill, Stanford, UMass Medical Center10 subjects per site (40 total)Normal daily routine, no restrictions on diet or exerciseRemote monitoring of alarms in BP, call subject if not response to alarms
Ellen H Ullman, MSW's insight:

Thank you Joshua Levy for sharing this via Twitter

more...
No comment yet.